The ICGC continues to evolve with advancements in genomic technologies and computational biology. Future directions include expanding the scope of cancer types studied, integrating multi-omics data (such as proteomics and transcriptomics), and developing more sophisticated models to predict treatment responses. The consortium also aims to enhance global collaboration and data sharing, ensuring that the benefits of its research are widely accessible.
